nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—HRH4—stomach cancer	0.44	0.776	CbGaD
Doxepin—HTR1A—stomach cancer	0.127	0.224	CbGaD
Doxepin—ABCB1—Mitomycin—stomach cancer	0.0299	0.316	CbGbCtD
Doxepin—CYP2C9—Capecitabine—stomach cancer	0.0128	0.135	CbGbCtD
Doxepin—HRH2—gastric juice—stomach cancer	0.0119	0.187	CbGeAlD
Doxepin—CYP1A2—Fluorouracil—stomach cancer	0.00842	0.0889	CbGbCtD
Doxepin—ABCB1—Irinotecan—stomach cancer	0.00767	0.081	CbGbCtD
Doxepin—CYP2C9—Fluorouracil—stomach cancer	0.00758	0.0801	CbGbCtD
Doxepin—ABCB1—Docetaxel—stomach cancer	0.00562	0.0594	CbGbCtD
Doxepin—ORM1—bile—stomach cancer	0.00469	0.0734	CbGeAlD
Doxepin—CYP3A4—Irinotecan—stomach cancer	0.00459	0.0486	CbGbCtD
Doxepin—CHRM3—muscle of abdomen—stomach cancer	0.00429	0.0673	CbGeAlD
Doxepin—ABCB1—Doxorubicin—stomach cancer	0.00419	0.0443	CbGbCtD
Doxepin—ABCB1—Methotrexate—stomach cancer	0.00406	0.0429	CbGbCtD
Doxepin—CYP2D6—Doxorubicin—stomach cancer	0.00395	0.0417	CbGbCtD
Doxepin—CYP3A4—Docetaxel—stomach cancer	0.00337	0.0356	CbGbCtD
Doxepin—HTR2A—myenteric nerve plexus—stomach cancer	0.00305	0.0478	CbGeAlD
Doxepin—CYP3A4—Doxorubicin—stomach cancer	0.00251	0.0265	CbGbCtD
Doxepin—HRH4—hematopoietic system—stomach cancer	0.00249	0.0391	CbGeAlD
Doxepin—HTR2A—vagus nerve—stomach cancer	0.00203	0.0319	CbGeAlD
Doxepin—HTR2A—vein—stomach cancer	0.00196	0.0308	CbGeAlD
Doxepin—HRH4—bone marrow—stomach cancer	0.0016	0.025	CbGeAlD
Doxepin—ORM1—gall bladder—stomach cancer	0.0013	0.0204	CbGeAlD
Doxepin—HRH2—hematopoietic system—stomach cancer	0.00105	0.0164	CbGeAlD
Doxepin—CHRM5—epithelium—stomach cancer	0.000914	0.0143	CbGeAlD
Doxepin—ADRA1D—epithelium—stomach cancer	0.000817	0.0128	CbGeAlD
Doxepin—ORM1—hematopoietic system—stomach cancer	0.000736	0.0115	CbGeAlD
Doxepin—HRH2—digestive system—stomach cancer	0.000728	0.0114	CbGeAlD
Doxepin—SLC6A4—hematopoietic system—stomach cancer	0.000627	0.00983	CbGeAlD
Doxepin—HTR2A—blood vessel—stomach cancer	0.000623	0.00977	CbGeAlD
Doxepin—HRH2—endocrine gland—stomach cancer	0.000602	0.00942	CbGeAlD
Doxepin—HTR1A—hematopoietic system—stomach cancer	0.000557	0.00873	CbGeAlD
Doxepin—HTR2B—smooth muscle tissue—stomach cancer	0.000548	0.00858	CbGeAlD
Doxepin—HRH2—liver—stomach cancer	0.000542	0.0085	CbGeAlD
Doxepin—CYP2C19—hematopoietic system—stomach cancer	0.00052	0.00814	CbGeAlD
Doxepin—ADRA1D—endocrine gland—stomach cancer	0.000514	0.00805	CbGeAlD
Doxepin—ADRA1A—hematopoietic system—stomach cancer	0.000513	0.00804	CbGeAlD
Doxepin—KCNH2—hematopoietic system—stomach cancer	0.000496	0.00777	CbGeAlD
Doxepin—CHRM3—smooth muscle tissue—stomach cancer	0.000493	0.00772	CbGeAlD
Doxepin—ORM1—bone marrow—stomach cancer	0.000472	0.00739	CbGeAlD
Doxepin—ADRA1A—epithelium—stomach cancer	0.000469	0.00735	CbGeAlD
Doxepin—SLC6A4—digestive system—stomach cancer	0.000436	0.00683	CbGeAlD
Doxepin—HTR2B—digestive system—stomach cancer	0.000432	0.00677	CbGeAlD
Doxepin—Promethazine—HRH4—stomach cancer	0.000431	0.176	CrCbGaD
Doxepin—CYP1A2—hematopoietic system—stomach cancer	0.000425	0.00665	CbGeAlD
Doxepin—ORM1—endocrine gland—stomach cancer	0.000423	0.00663	CbGeAlD
Doxepin—HRH2—lymph node—stomach cancer	0.000416	0.00652	CbGeAlD
Doxepin—ABCB1—blood vessel—stomach cancer	0.000409	0.0064	CbGeAlD
Doxepin—CYP2C9—hematopoietic system—stomach cancer	0.000403	0.00631	CbGeAlD
Doxepin—ADRA2C—pancreas—stomach cancer	0.000398	0.00624	CbGeAlD
Doxepin—HRH1—hematopoietic system—stomach cancer	0.000397	0.00623	CbGeAlD
Doxepin—CHRM2—endocrine gland—stomach cancer	0.000395	0.00618	CbGeAlD
Doxepin—ADRA2A—hematopoietic system—stomach cancer	0.00039	0.00612	CbGeAlD
Doxepin—CHRM3—digestive system—stomach cancer	0.000389	0.00609	CbGeAlD
Doxepin—ORM1—liver—stomach cancer	0.000381	0.00598	CbGeAlD
Doxepin—HRH1—epithelium—stomach cancer	0.000363	0.00569	CbGeAlD
Doxepin—CYP2C19—digestive system—stomach cancer	0.000362	0.00566	CbGeAlD
Doxepin—ADRA1A—lymphoid tissue—stomach cancer	0.000362	0.00566	CbGeAlD
Doxepin—SLC6A4—endocrine gland—stomach cancer	0.00036	0.00565	CbGeAlD
Doxepin—CHRM1—endocrine gland—stomach cancer	0.000359	0.00563	CbGeAlD
Doxepin—HRH1—smooth muscle tissue—stomach cancer	0.00035	0.00548	CbGeAlD
Doxepin—HTR2A—hematopoietic system—stomach cancer	0.000332	0.0052	CbGeAlD
Doxepin—Amitriptyline—HRH4—stomach cancer	0.00033	0.134	CrCbGaD
Doxepin—CHRM3—endocrine gland—stomach cancer	0.000321	0.00503	CbGeAlD
Doxepin—HTR1A—endocrine gland—stomach cancer	0.00032	0.00501	CbGeAlD
Doxepin—KCNH2—bone marrow—stomach cancer	0.000318	0.00498	CbGeAlD
Doxepin—ADRA2A—pancreas—stomach cancer	0.000318	0.00498	CbGeAlD
Doxepin—SLC6A2—endocrine gland—stomach cancer	0.000317	0.00497	CbGeAlD
Doxepin—CYP3A4—hematopoietic system—stomach cancer	0.000307	0.00481	CbGeAlD
Doxepin—HTR2A—epithelium—stomach cancer	0.000303	0.00475	CbGeAlD
Doxepin—CYP2D6—hematopoietic system—stomach cancer	0.000302	0.00474	CbGeAlD
Doxepin—CYP2C19—endocrine gland—stomach cancer	0.000299	0.00468	CbGeAlD
Doxepin—CYP1A2—digestive system—stomach cancer	0.000295	0.00463	CbGeAlD
Doxepin—ADRA1A—endocrine gland—stomach cancer	0.000295	0.00462	CbGeAlD
Doxepin—ORM1—lymph node—stomach cancer	0.000292	0.00458	CbGeAlD
Doxepin—HTR2A—smooth muscle tissue—stomach cancer	0.000292	0.00458	CbGeAlD
Doxepin—DRD2—endocrine gland—stomach cancer	0.000289	0.00453	CbGeAlD
Doxepin—KCNH2—endocrine gland—stomach cancer	0.000285	0.00446	CbGeAlD
Doxepin—CYP2C9—digestive system—stomach cancer	0.00028	0.00439	CbGeAlD
Doxepin—HRH1—digestive system—stomach cancer	0.000276	0.00433	CbGeAlD
Doxepin—CYP2C19—liver—stomach cancer	0.000269	0.00422	CbGeAlD
Doxepin—ADRA1A—liver—stomach cancer	0.000266	0.00417	CbGeAlD
Doxepin—ADRA2C—liver—stomach cancer	0.000253	0.00397	CbGeAlD
Doxepin—HTR2B—lymph node—stomach cancer	0.000247	0.00387	CbGeAlD
Doxepin—CYP1A2—endocrine gland—stomach cancer	0.000244	0.00382	CbGeAlD
Doxepin—CYP2C9—endocrine gland—stomach cancer	0.000232	0.00363	CbGeAlD
Doxepin—HTR2A—digestive system—stomach cancer	0.000231	0.00362	CbGeAlD
Doxepin—HRH1—endocrine gland—stomach cancer	0.000228	0.00358	CbGeAlD
Doxepin—ADRA2A—endocrine gland—stomach cancer	0.000224	0.00351	CbGeAlD
Doxepin—Clomipramine—GSTP1—stomach cancer	0.000224	0.0913	CrCbGaD
Doxepin—CYP1A2—liver—stomach cancer	0.00022	0.00345	CbGeAlD
Doxepin—SLC6A2—lymph node—stomach cancer	0.000219	0.00344	CbGeAlD
Doxepin—ABCB1—hematopoietic system—stomach cancer	0.000218	0.00341	CbGeAlD
Doxepin—CYP3A4—digestive system—stomach cancer	0.000214	0.00335	CbGeAlD
Doxepin—CYP2D6—digestive system—stomach cancer	0.00021	0.00329	CbGeAlD
Doxepin—CYP2C9—liver—stomach cancer	0.000209	0.00327	CbGeAlD
Doxepin—ABCB1—epithelium—stomach cancer	0.000199	0.00311	CbGeAlD
Doxepin—KCNH2—lymph node—stomach cancer	0.000197	0.00309	CbGeAlD
Doxepin—ADRA2C—lymph node—stomach cancer	0.000194	0.00304	CbGeAlD
Doxepin—HTR2A—endocrine gland—stomach cancer	0.000191	0.00299	CbGeAlD
Doxepin—Thiothixene—HTR1A—stomach cancer	0.000178	0.0725	CrCbGaD
Doxepin—ABCB1—pancreas—stomach cancer	0.000177	0.00277	CbGeAlD
Doxepin—CYP3A4—endocrine gland—stomach cancer	0.000177	0.00277	CbGeAlD
Doxepin—CYP2D6—endocrine gland—stomach cancer	0.000174	0.00272	CbGeAlD
Doxepin—HTR2A—liver—stomach cancer	0.000172	0.00269	CbGeAlD
Doxepin—CYP3A4—liver—stomach cancer	0.000159	0.00249	CbGeAlD
Doxepin—HRH1—lymph node—stomach cancer	0.000158	0.00247	CbGeAlD
Doxepin—CYP2D6—liver—stomach cancer	0.000157	0.00245	CbGeAlD
Doxepin—ADRA2A—lymph node—stomach cancer	0.000155	0.00243	CbGeAlD
Doxepin—ABCB1—lymphoid tissue—stomach cancer	0.000153	0.0024	CbGeAlD
Doxepin—ABCB1—digestive system—stomach cancer	0.000151	0.00237	CbGeAlD
Doxepin—ABCB1—bone marrow—stomach cancer	0.000139	0.00218	CbGeAlD
Doxepin—Nortriptyline—HTR1A—stomach cancer	0.000137	0.056	CrCbGaD
Doxepin—Desipramine—CYP2A6—stomach cancer	0.00013	0.053	CrCbGaD
Doxepin—Trimipramine—HTR1A—stomach cancer	0.000129	0.0527	CrCbGaD
Doxepin—Desipramine—ADRB1—stomach cancer	0.000126	0.0515	CrCbGaD
Doxepin—ABCB1—endocrine gland—stomach cancer	0.000125	0.00196	CbGeAlD
Doxepin—Desipramine—HTR1A—stomach cancer	0.000113	0.0461	CrCbGaD
Doxepin—ABCB1—liver—stomach cancer	0.000113	0.00177	CbGeAlD
Doxepin—Oxcarbazepine—ALB—stomach cancer	0.00011	0.0448	CrCbGaD
Doxepin—Desipramine—ADRB2—stomach cancer	0.000106	0.0433	CrCbGaD
Doxepin—Imipramine—HTR1A—stomach cancer	9.59e-05	0.0391	CrCbGaD
Doxepin—Amitriptyline—HTR1A—stomach cancer	9.53e-05	0.0389	CrCbGaD
Doxepin—ABCB1—lymph node—stomach cancer	8.64e-05	0.00135	CbGeAlD
Doxepin—Thiothixene—ALB—stomach cancer	7.98e-05	0.0325	CrCbGaD
Doxepin—Insomnia—Capecitabine—stomach cancer	7.53e-05	0.000462	CcSEcCtD
Doxepin—Hypoaesthesia—Doxorubicin—stomach cancer	7.51e-05	0.000461	CcSEcCtD
Doxepin—Rash—Fluorouracil—stomach cancer	7.51e-05	0.000461	CcSEcCtD
Doxepin—Dermatitis—Fluorouracil—stomach cancer	7.5e-05	0.000461	CcSEcCtD
Doxepin—Pharyngitis—Doxorubicin—stomach cancer	7.5e-05	0.00046	CcSEcCtD
Doxepin—Paraesthesia—Capecitabine—stomach cancer	7.47e-05	0.000459	CcSEcCtD
Doxepin—Decreased appetite—Docetaxel—stomach cancer	7.47e-05	0.000459	CcSEcCtD
Doxepin—Headache—Fluorouracil—stomach cancer	7.46e-05	0.000458	CcSEcCtD
Doxepin—Urinary tract disorder—Doxorubicin—stomach cancer	7.46e-05	0.000458	CcSEcCtD
Doxepin—Oedema peripheral—Doxorubicin—stomach cancer	7.44e-05	0.000457	CcSEcCtD
Doxepin—Dysgeusia—Methotrexate—stomach cancer	7.43e-05	0.000457	CcSEcCtD
Doxepin—Gastrointestinal disorder—Docetaxel—stomach cancer	7.42e-05	0.000456	CcSEcCtD
Doxepin—Connective tissue disorder—Doxorubicin—stomach cancer	7.42e-05	0.000456	CcSEcCtD
Doxepin—Dyspnoea—Capecitabine—stomach cancer	7.42e-05	0.000456	CcSEcCtD
Doxepin—Fatigue—Docetaxel—stomach cancer	7.41e-05	0.000455	CcSEcCtD
Doxepin—Angiopathy—Epirubicin—stomach cancer	7.4e-05	0.000455	CcSEcCtD
Doxepin—Urethral disorder—Doxorubicin—stomach cancer	7.4e-05	0.000455	CcSEcCtD
Doxepin—Nausea—Irinotecan—stomach cancer	7.39e-05	0.000454	CcSEcCtD
Doxepin—Immune system disorder—Epirubicin—stomach cancer	7.37e-05	0.000453	CcSEcCtD
Doxepin—Mediastinal disorder—Epirubicin—stomach cancer	7.36e-05	0.000452	CcSEcCtD
Doxepin—Constipation—Docetaxel—stomach cancer	7.35e-05	0.000452	CcSEcCtD
Doxepin—Pain—Docetaxel—stomach cancer	7.35e-05	0.000452	CcSEcCtD
Doxepin—Back pain—Methotrexate—stomach cancer	7.34e-05	0.000451	CcSEcCtD
Doxepin—Dyspepsia—Capecitabine—stomach cancer	7.33e-05	0.00045	CcSEcCtD
Doxepin—Chills—Epirubicin—stomach cancer	7.32e-05	0.00045	CcSEcCtD
Doxepin—Arrhythmia—Epirubicin—stomach cancer	7.29e-05	0.000448	CcSEcCtD
Doxepin—Decreased appetite—Capecitabine—stomach cancer	7.24e-05	0.000444	CcSEcCtD
Doxepin—Alopecia—Epirubicin—stomach cancer	7.21e-05	0.000443	CcSEcCtD
Doxepin—Gastrointestinal disorder—Capecitabine—stomach cancer	7.19e-05	0.000441	CcSEcCtD
Doxepin—Fatigue—Capecitabine—stomach cancer	7.18e-05	0.000441	CcSEcCtD
Doxepin—Vision blurred—Methotrexate—stomach cancer	7.15e-05	0.000439	CcSEcCtD
Doxepin—Mental disorder—Epirubicin—stomach cancer	7.15e-05	0.000439	CcSEcCtD
Doxepin—Pain—Capecitabine—stomach cancer	7.12e-05	0.000437	CcSEcCtD
Doxepin—Constipation—Capecitabine—stomach cancer	7.12e-05	0.000437	CcSEcCtD
Doxepin—Erythema—Epirubicin—stomach cancer	7.1e-05	0.000436	CcSEcCtD
Doxepin—Malnutrition—Epirubicin—stomach cancer	7.1e-05	0.000436	CcSEcCtD
Doxepin—Feeling abnormal—Docetaxel—stomach cancer	7.08e-05	0.000435	CcSEcCtD
Doxepin—Nausea—Fluorouracil—stomach cancer	7.07e-05	0.000435	CcSEcCtD
Doxepin—Eye disorder—Doxorubicin—stomach cancer	7.06e-05	0.000433	CcSEcCtD
Doxepin—Ill-defined disorder—Methotrexate—stomach cancer	7.04e-05	0.000433	CcSEcCtD
Doxepin—Tinnitus—Doxorubicin—stomach cancer	7.04e-05	0.000432	CcSEcCtD
Doxepin—Gastrointestinal pain—Docetaxel—stomach cancer	7.03e-05	0.000432	CcSEcCtD
Doxepin—Anaemia—Methotrexate—stomach cancer	7.02e-05	0.000431	CcSEcCtD
Doxepin—Flushing—Doxorubicin—stomach cancer	7.01e-05	0.00043	CcSEcCtD
Doxepin—Cardiac disorder—Doxorubicin—stomach cancer	7.01e-05	0.00043	CcSEcCtD
Doxepin—Flatulence—Epirubicin—stomach cancer	7e-05	0.00043	CcSEcCtD
Doxepin—Tension—Epirubicin—stomach cancer	6.97e-05	0.000428	CcSEcCtD
Doxepin—Dysgeusia—Epirubicin—stomach cancer	6.96e-05	0.000427	CcSEcCtD
Doxepin—Nervousness—Epirubicin—stomach cancer	6.9e-05	0.000424	CcSEcCtD
Doxepin—Back pain—Epirubicin—stomach cancer	6.87e-05	0.000422	CcSEcCtD
Doxepin—Feeling abnormal—Capecitabine—stomach cancer	6.86e-05	0.000421	CcSEcCtD
Doxepin—Angiopathy—Doxorubicin—stomach cancer	6.85e-05	0.000421	CcSEcCtD
Doxepin—Malaise—Methotrexate—stomach cancer	6.85e-05	0.00042	CcSEcCtD
Doxepin—Muscle spasms—Epirubicin—stomach cancer	6.83e-05	0.00042	CcSEcCtD
Doxepin—Immune system disorder—Doxorubicin—stomach cancer	6.82e-05	0.000419	CcSEcCtD
Doxepin—Vertigo—Methotrexate—stomach cancer	6.82e-05	0.000419	CcSEcCtD
Doxepin—Gastrointestinal pain—Capecitabine—stomach cancer	6.81e-05	0.000418	CcSEcCtD
Doxepin—Mediastinal disorder—Doxorubicin—stomach cancer	6.81e-05	0.000418	CcSEcCtD
Doxepin—Abdominal pain—Docetaxel—stomach cancer	6.8e-05	0.000417	CcSEcCtD
Doxepin—Body temperature increased—Docetaxel—stomach cancer	6.8e-05	0.000417	CcSEcCtD
Doxepin—Leukopenia—Methotrexate—stomach cancer	6.8e-05	0.000417	CcSEcCtD
Doxepin—Chills—Doxorubicin—stomach cancer	6.78e-05	0.000416	CcSEcCtD
Doxepin—Arrhythmia—Doxorubicin—stomach cancer	6.75e-05	0.000414	CcSEcCtD
Doxepin—Vision blurred—Epirubicin—stomach cancer	6.7e-05	0.000411	CcSEcCtD
Doxepin—Alopecia—Doxorubicin—stomach cancer	6.67e-05	0.00041	CcSEcCtD
Doxepin—Cough—Methotrexate—stomach cancer	6.62e-05	0.000407	CcSEcCtD
Doxepin—Mental disorder—Doxorubicin—stomach cancer	6.62e-05	0.000406	CcSEcCtD
Doxepin—Urticaria—Capecitabine—stomach cancer	6.61e-05	0.000406	CcSEcCtD
Doxepin—Ill-defined disorder—Epirubicin—stomach cancer	6.59e-05	0.000405	CcSEcCtD
Doxepin—Abdominal pain—Capecitabine—stomach cancer	6.58e-05	0.000404	CcSEcCtD
Doxepin—Body temperature increased—Capecitabine—stomach cancer	6.58e-05	0.000404	CcSEcCtD
Doxepin—Convulsion—Methotrexate—stomach cancer	6.58e-05	0.000404	CcSEcCtD
Doxepin—Erythema—Doxorubicin—stomach cancer	6.57e-05	0.000404	CcSEcCtD
Doxepin—Malnutrition—Doxorubicin—stomach cancer	6.57e-05	0.000404	CcSEcCtD
Doxepin—Anaemia—Epirubicin—stomach cancer	6.57e-05	0.000403	CcSEcCtD
Doxepin—Agitation—Epirubicin—stomach cancer	6.53e-05	0.000401	CcSEcCtD
Doxepin—Flatulence—Doxorubicin—stomach cancer	6.48e-05	0.000398	CcSEcCtD
Doxepin—Arthralgia—Methotrexate—stomach cancer	6.46e-05	0.000397	CcSEcCtD
Doxepin—Myalgia—Methotrexate—stomach cancer	6.46e-05	0.000397	CcSEcCtD
Doxepin—Chest pain—Methotrexate—stomach cancer	6.46e-05	0.000397	CcSEcCtD
Doxepin—Tension—Doxorubicin—stomach cancer	6.45e-05	0.000396	CcSEcCtD
Doxepin—Dysgeusia—Doxorubicin—stomach cancer	6.44e-05	0.000395	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	6.42e-05	0.000394	CcSEcCtD
Doxepin—Malaise—Epirubicin—stomach cancer	6.41e-05	0.000394	CcSEcCtD
Doxepin—Discomfort—Methotrexate—stomach cancer	6.39e-05	0.000392	CcSEcCtD
Doxepin—Nervousness—Doxorubicin—stomach cancer	6.38e-05	0.000392	CcSEcCtD
Doxepin—Vertigo—Epirubicin—stomach cancer	6.38e-05	0.000392	CcSEcCtD
Doxepin—Syncope—Epirubicin—stomach cancer	6.37e-05	0.000391	CcSEcCtD
Doxepin—Leukopenia—Epirubicin—stomach cancer	6.36e-05	0.000391	CcSEcCtD
Doxepin—Back pain—Doxorubicin—stomach cancer	6.36e-05	0.000391	CcSEcCtD
Doxepin—Hypersensitivity—Docetaxel—stomach cancer	6.33e-05	0.000389	CcSEcCtD
Doxepin—Muscle spasms—Doxorubicin—stomach cancer	6.32e-05	0.000388	CcSEcCtD
Doxepin—Clomipramine—ALB—stomach cancer	6.31e-05	0.0257	CrCbGaD
Doxepin—Palpitations—Epirubicin—stomach cancer	6.28e-05	0.000386	CcSEcCtD
Doxepin—Confusional state—Methotrexate—stomach cancer	6.25e-05	0.000384	CcSEcCtD
Doxepin—Loss of consciousness—Epirubicin—stomach cancer	6.24e-05	0.000384	CcSEcCtD
Doxepin—Cough—Epirubicin—stomach cancer	6.2e-05	0.000381	CcSEcCtD
Doxepin—Vision blurred—Doxorubicin—stomach cancer	6.2e-05	0.000381	CcSEcCtD
Doxepin—Asthenia—Docetaxel—stomach cancer	6.17e-05	0.000379	CcSEcCtD
Doxepin—Nortriptyline—ALB—stomach cancer	6.16e-05	0.0251	CrCbGaD
Doxepin—Convulsion—Epirubicin—stomach cancer	6.16e-05	0.000378	CcSEcCtD
Doxepin—Infection—Methotrexate—stomach cancer	6.16e-05	0.000378	CcSEcCtD
Doxepin—Hypertension—Epirubicin—stomach cancer	6.13e-05	0.000377	CcSEcCtD
Doxepin—Hypersensitivity—Capecitabine—stomach cancer	6.13e-05	0.000377	CcSEcCtD
Doxepin—Ill-defined disorder—Doxorubicin—stomach cancer	6.1e-05	0.000375	CcSEcCtD
Doxepin—Pruritus—Docetaxel—stomach cancer	6.08e-05	0.000374	CcSEcCtD
Doxepin—Nervous system disorder—Methotrexate—stomach cancer	6.08e-05	0.000373	CcSEcCtD
Doxepin—Anaemia—Doxorubicin—stomach cancer	6.08e-05	0.000373	CcSEcCtD
Doxepin—Thrombocytopenia—Methotrexate—stomach cancer	6.07e-05	0.000373	CcSEcCtD
Doxepin—Myalgia—Epirubicin—stomach cancer	6.05e-05	0.000372	CcSEcCtD
Doxepin—Chest pain—Epirubicin—stomach cancer	6.05e-05	0.000372	CcSEcCtD
Doxepin—Arthralgia—Epirubicin—stomach cancer	6.05e-05	0.000372	CcSEcCtD
Doxepin—Agitation—Doxorubicin—stomach cancer	6.04e-05	0.000371	CcSEcCtD
Doxepin—Anxiety—Epirubicin—stomach cancer	6.03e-05	0.00037	CcSEcCtD
Doxepin—Skin disorder—Methotrexate—stomach cancer	6.02e-05	0.00037	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	6.01e-05	0.000369	CcSEcCtD
Doxepin—Hyperhidrosis—Methotrexate—stomach cancer	5.99e-05	0.000368	CcSEcCtD
Doxepin—Discomfort—Epirubicin—stomach cancer	5.98e-05	0.000367	CcSEcCtD
Doxepin—Asthenia—Capecitabine—stomach cancer	5.97e-05	0.000367	CcSEcCtD
Doxepin—Malaise—Doxorubicin—stomach cancer	5.93e-05	0.000364	CcSEcCtD
Doxepin—Dry mouth—Epirubicin—stomach cancer	5.92e-05	0.000363	CcSEcCtD
Doxepin—Vertigo—Doxorubicin—stomach cancer	5.91e-05	0.000363	CcSEcCtD
Doxepin—Anorexia—Methotrexate—stomach cancer	5.91e-05	0.000363	CcSEcCtD
Doxepin—Syncope—Doxorubicin—stomach cancer	5.9e-05	0.000362	CcSEcCtD
Doxepin—Pruritus—Capecitabine—stomach cancer	5.89e-05	0.000362	CcSEcCtD
Doxepin—Leukopenia—Doxorubicin—stomach cancer	5.88e-05	0.000361	CcSEcCtD
Doxepin—Diarrhoea—Docetaxel—stomach cancer	5.88e-05	0.000361	CcSEcCtD
Doxepin—Confusional state—Epirubicin—stomach cancer	5.85e-05	0.000359	CcSEcCtD
Doxepin—Palpitations—Doxorubicin—stomach cancer	5.81e-05	0.000357	CcSEcCtD
Doxepin—Oedema—Epirubicin—stomach cancer	5.8e-05	0.000356	CcSEcCtD
Doxepin—Hypotension—Methotrexate—stomach cancer	5.79e-05	0.000356	CcSEcCtD
Doxepin—Loss of consciousness—Doxorubicin—stomach cancer	5.78e-05	0.000355	CcSEcCtD
Doxepin—Infection—Epirubicin—stomach cancer	5.76e-05	0.000354	CcSEcCtD
Doxepin—Cough—Doxorubicin—stomach cancer	5.74e-05	0.000352	CcSEcCtD
Doxepin—Shock—Epirubicin—stomach cancer	5.7e-05	0.00035	CcSEcCtD
Doxepin—Convulsion—Doxorubicin—stomach cancer	5.7e-05	0.00035	CcSEcCtD
Doxepin—Diarrhoea—Capecitabine—stomach cancer	5.69e-05	0.00035	CcSEcCtD
Doxepin—Nervous system disorder—Epirubicin—stomach cancer	5.69e-05	0.000349	CcSEcCtD
Doxepin—Dizziness—Docetaxel—stomach cancer	5.68e-05	0.000349	CcSEcCtD
Doxepin—Thrombocytopenia—Epirubicin—stomach cancer	5.68e-05	0.000349	CcSEcCtD
Doxepin—Hypertension—Doxorubicin—stomach cancer	5.68e-05	0.000349	CcSEcCtD
Doxepin—Tachycardia—Epirubicin—stomach cancer	5.66e-05	0.000348	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Methotrexate—stomach cancer	5.65e-05	0.000347	CcSEcCtD
Doxepin—Skin disorder—Epirubicin—stomach cancer	5.63e-05	0.000346	CcSEcCtD
Doxepin—Hyperhidrosis—Epirubicin—stomach cancer	5.61e-05	0.000344	CcSEcCtD
Doxepin—Insomnia—Methotrexate—stomach cancer	5.6e-05	0.000344	CcSEcCtD
Doxepin—Chest pain—Doxorubicin—stomach cancer	5.6e-05	0.000344	CcSEcCtD
Doxepin—Myalgia—Doxorubicin—stomach cancer	5.6e-05	0.000344	CcSEcCtD
Doxepin—Arthralgia—Doxorubicin—stomach cancer	5.6e-05	0.000344	CcSEcCtD
Doxepin—Anxiety—Doxorubicin—stomach cancer	5.58e-05	0.000343	CcSEcCtD
Doxepin—Paraesthesia—Methotrexate—stomach cancer	5.56e-05	0.000342	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	5.56e-05	0.000341	CcSEcCtD
Doxepin—Discomfort—Doxorubicin—stomach cancer	5.53e-05	0.00034	CcSEcCtD
Doxepin—Anorexia—Epirubicin—stomach cancer	5.53e-05	0.000339	CcSEcCtD
Doxepin—Dyspnoea—Methotrexate—stomach cancer	5.52e-05	0.000339	CcSEcCtD
Doxepin—Somnolence—Methotrexate—stomach cancer	5.51e-05	0.000338	CcSEcCtD
Doxepin—Dizziness—Capecitabine—stomach cancer	5.5e-05	0.000338	CcSEcCtD
Doxepin—Dry mouth—Doxorubicin—stomach cancer	5.47e-05	0.000336	CcSEcCtD
Doxepin—Vomiting—Docetaxel—stomach cancer	5.47e-05	0.000336	CcSEcCtD
Doxepin—Dyspepsia—Methotrexate—stomach cancer	5.45e-05	0.000335	CcSEcCtD
Doxepin—Rash—Docetaxel—stomach cancer	5.42e-05	0.000333	CcSEcCtD
Doxepin—Hypotension—Epirubicin—stomach cancer	5.42e-05	0.000333	CcSEcCtD
Doxepin—Dermatitis—Docetaxel—stomach cancer	5.42e-05	0.000333	CcSEcCtD
Doxepin—Confusional state—Doxorubicin—stomach cancer	5.41e-05	0.000332	CcSEcCtD
Doxepin—Decreased appetite—Methotrexate—stomach cancer	5.39e-05	0.000331	CcSEcCtD
Doxepin—Headache—Docetaxel—stomach cancer	5.39e-05	0.000331	CcSEcCtD
Doxepin—Oedema—Doxorubicin—stomach cancer	5.37e-05	0.00033	CcSEcCtD
Doxepin—Gastrointestinal disorder—Methotrexate—stomach cancer	5.35e-05	0.000329	CcSEcCtD
Doxepin—Fatigue—Methotrexate—stomach cancer	5.34e-05	0.000328	CcSEcCtD
Doxepin—Infection—Doxorubicin—stomach cancer	5.33e-05	0.000327	CcSEcCtD
Doxepin—Pain—Methotrexate—stomach cancer	5.3e-05	0.000325	CcSEcCtD
Doxepin—Vomiting—Capecitabine—stomach cancer	5.29e-05	0.000325	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Epirubicin—stomach cancer	5.28e-05	0.000324	CcSEcCtD
Doxepin—Shock—Doxorubicin—stomach cancer	5.28e-05	0.000324	CcSEcCtD
Doxepin—Nervous system disorder—Doxorubicin—stomach cancer	5.26e-05	0.000323	CcSEcCtD
Doxepin—Thrombocytopenia—Doxorubicin—stomach cancer	5.25e-05	0.000323	CcSEcCtD
Doxepin—Rash—Capecitabine—stomach cancer	5.25e-05	0.000322	CcSEcCtD
Doxepin—Insomnia—Epirubicin—stomach cancer	5.24e-05	0.000322	CcSEcCtD
Doxepin—Dermatitis—Capecitabine—stomach cancer	5.24e-05	0.000322	CcSEcCtD
Doxepin—Tachycardia—Doxorubicin—stomach cancer	5.24e-05	0.000322	CcSEcCtD
Doxepin—Headache—Capecitabine—stomach cancer	5.21e-05	0.00032	CcSEcCtD
Doxepin—Skin disorder—Doxorubicin—stomach cancer	5.21e-05	0.00032	CcSEcCtD
Doxepin—Paraesthesia—Epirubicin—stomach cancer	5.21e-05	0.00032	CcSEcCtD
Doxepin—Hyperhidrosis—Doxorubicin—stomach cancer	5.19e-05	0.000319	CcSEcCtD
Doxepin—Dyspnoea—Epirubicin—stomach cancer	5.17e-05	0.000318	CcSEcCtD
Doxepin—Somnolence—Epirubicin—stomach cancer	5.15e-05	0.000317	CcSEcCtD
Doxepin—Anorexia—Doxorubicin—stomach cancer	5.11e-05	0.000314	CcSEcCtD
Doxepin—Nausea—Docetaxel—stomach cancer	5.11e-05	0.000314	CcSEcCtD
Doxepin—Feeling abnormal—Methotrexate—stomach cancer	5.11e-05	0.000314	CcSEcCtD
Doxepin—Dyspepsia—Epirubicin—stomach cancer	5.1e-05	0.000313	CcSEcCtD
Doxepin—Gastrointestinal pain—Methotrexate—stomach cancer	5.07e-05	0.000311	CcSEcCtD
Doxepin—Decreased appetite—Epirubicin—stomach cancer	5.04e-05	0.00031	CcSEcCtD
Doxepin—Hypotension—Doxorubicin—stomach cancer	5.01e-05	0.000308	CcSEcCtD
Doxepin—Gastrointestinal disorder—Epirubicin—stomach cancer	5.01e-05	0.000307	CcSEcCtD
Doxepin—Fatigue—Epirubicin—stomach cancer	5e-05	0.000307	CcSEcCtD
Doxepin—Pain—Epirubicin—stomach cancer	4.96e-05	0.000305	CcSEcCtD
Doxepin—Constipation—Epirubicin—stomach cancer	4.96e-05	0.000305	CcSEcCtD
Doxepin—Nausea—Capecitabine—stomach cancer	4.94e-05	0.000304	CcSEcCtD
Doxepin—Urticaria—Methotrexate—stomach cancer	4.92e-05	0.000302	CcSEcCtD
Doxepin—Body temperature increased—Methotrexate—stomach cancer	4.9e-05	0.000301	CcSEcCtD
Doxepin—Abdominal pain—Methotrexate—stomach cancer	4.9e-05	0.000301	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	4.89e-05	0.0003	CcSEcCtD
Doxepin—Insomnia—Doxorubicin—stomach cancer	4.85e-05	0.000298	CcSEcCtD
Doxepin—Paraesthesia—Doxorubicin—stomach cancer	4.82e-05	0.000296	CcSEcCtD
Doxepin—Dyspnoea—Doxorubicin—stomach cancer	4.78e-05	0.000294	CcSEcCtD
Doxepin—Feeling abnormal—Epirubicin—stomach cancer	4.78e-05	0.000293	CcSEcCtD
Doxepin—Somnolence—Doxorubicin—stomach cancer	4.77e-05	0.000293	CcSEcCtD
Doxepin—Gastrointestinal pain—Epirubicin—stomach cancer	4.74e-05	0.000291	CcSEcCtD
Doxepin—Dyspepsia—Doxorubicin—stomach cancer	4.72e-05	0.00029	CcSEcCtD
Doxepin—Decreased appetite—Doxorubicin—stomach cancer	4.66e-05	0.000286	CcSEcCtD
Doxepin—Gastrointestinal disorder—Doxorubicin—stomach cancer	4.63e-05	0.000284	CcSEcCtD
Doxepin—Fatigue—Doxorubicin—stomach cancer	4.63e-05	0.000284	CcSEcCtD
Doxepin—Urticaria—Epirubicin—stomach cancer	4.61e-05	0.000283	CcSEcCtD
Doxepin—Pain—Doxorubicin—stomach cancer	4.59e-05	0.000282	CcSEcCtD
Doxepin—Constipation—Doxorubicin—stomach cancer	4.59e-05	0.000282	CcSEcCtD
Doxepin—Abdominal pain—Epirubicin—stomach cancer	4.58e-05	0.000282	CcSEcCtD
Doxepin—Body temperature increased—Epirubicin—stomach cancer	4.58e-05	0.000282	CcSEcCtD
Doxepin—Hypersensitivity—Methotrexate—stomach cancer	4.57e-05	0.00028	CcSEcCtD
Doxepin—Asthenia—Methotrexate—stomach cancer	4.45e-05	0.000273	CcSEcCtD
Doxepin—Feeling abnormal—Doxorubicin—stomach cancer	4.42e-05	0.000272	CcSEcCtD
Doxepin—Gastrointestinal pain—Doxorubicin—stomach cancer	4.39e-05	0.000269	CcSEcCtD
Doxepin—Pruritus—Methotrexate—stomach cancer	4.38e-05	0.000269	CcSEcCtD
Doxepin—Amitriptyline—ALB—stomach cancer	4.28e-05	0.0174	CrCbGaD
Doxepin—Hypersensitivity—Epirubicin—stomach cancer	4.27e-05	0.000262	CcSEcCtD
Doxepin—Urticaria—Doxorubicin—stomach cancer	4.26e-05	0.000262	CcSEcCtD
Doxepin—Abdominal pain—Doxorubicin—stomach cancer	4.24e-05	0.00026	CcSEcCtD
Doxepin—Body temperature increased—Doxorubicin—stomach cancer	4.24e-05	0.00026	CcSEcCtD
Doxepin—Diarrhoea—Methotrexate—stomach cancer	4.24e-05	0.00026	CcSEcCtD
Doxepin—Asthenia—Epirubicin—stomach cancer	4.16e-05	0.000256	CcSEcCtD
Doxepin—Pruritus—Epirubicin—stomach cancer	4.1e-05	0.000252	CcSEcCtD
Doxepin—Dizziness—Methotrexate—stomach cancer	4.1e-05	0.000252	CcSEcCtD
Doxepin—Diarrhoea—Epirubicin—stomach cancer	3.97e-05	0.000244	CcSEcCtD
Doxepin—Hypersensitivity—Doxorubicin—stomach cancer	3.95e-05	0.000243	CcSEcCtD
Doxepin—Vomiting—Methotrexate—stomach cancer	3.94e-05	0.000242	CcSEcCtD
Doxepin—Rash—Methotrexate—stomach cancer	3.91e-05	0.00024	CcSEcCtD
Doxepin—Dermatitis—Methotrexate—stomach cancer	3.9e-05	0.00024	CcSEcCtD
Doxepin—Headache—Methotrexate—stomach cancer	3.88e-05	0.000238	CcSEcCtD
Doxepin—Asthenia—Doxorubicin—stomach cancer	3.85e-05	0.000236	CcSEcCtD
Doxepin—Dizziness—Epirubicin—stomach cancer	3.83e-05	0.000236	CcSEcCtD
Doxepin—Pruritus—Doxorubicin—stomach cancer	3.8e-05	0.000233	CcSEcCtD
Doxepin—Vomiting—Epirubicin—stomach cancer	3.69e-05	0.000226	CcSEcCtD
Doxepin—Nausea—Methotrexate—stomach cancer	3.68e-05	0.000226	CcSEcCtD
Doxepin—Diarrhoea—Doxorubicin—stomach cancer	3.67e-05	0.000225	CcSEcCtD
Doxepin—Rash—Epirubicin—stomach cancer	3.66e-05	0.000225	CcSEcCtD
Doxepin—Dermatitis—Epirubicin—stomach cancer	3.65e-05	0.000224	CcSEcCtD
Doxepin—Headache—Epirubicin—stomach cancer	3.63e-05	0.000223	CcSEcCtD
Doxepin—Dizziness—Doxorubicin—stomach cancer	3.55e-05	0.000218	CcSEcCtD
Doxepin—Nausea—Epirubicin—stomach cancer	3.44e-05	0.000212	CcSEcCtD
Doxepin—Vomiting—Doxorubicin—stomach cancer	3.41e-05	0.00021	CcSEcCtD
Doxepin—Rash—Doxorubicin—stomach cancer	3.38e-05	0.000208	CcSEcCtD
Doxepin—Dermatitis—Doxorubicin—stomach cancer	3.38e-05	0.000208	CcSEcCtD
Doxepin—Headache—Doxorubicin—stomach cancer	3.36e-05	0.000206	CcSEcCtD
Doxepin—Nausea—Doxorubicin—stomach cancer	3.19e-05	0.000196	CcSEcCtD
Doxepin—CHRM1—Signaling by GPCR—IL6—stomach cancer	1.98e-06	1.81e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—JUN—stomach cancer	1.97e-06	1.81e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL6—stomach cancer	1.97e-06	1.81e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.97e-06	1.8e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—VEGFA—stomach cancer	1.96e-06	1.8e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—PIK3CA—stomach cancer	1.96e-06	1.8e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—VEGFA—stomach cancer	1.95e-06	1.79e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL6—stomach cancer	1.95e-06	1.79e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCND1—stomach cancer	1.95e-06	1.79e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL6—stomach cancer	1.95e-06	1.79e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—STAT3—stomach cancer	1.95e-06	1.79e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—JUN—stomach cancer	1.94e-06	1.78e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCND1—stomach cancer	1.94e-06	1.78e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PPARG—stomach cancer	1.94e-06	1.78e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—JUN—stomach cancer	1.94e-06	1.78e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCND1—stomach cancer	1.94e-06	1.78e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—STAT3—stomach cancer	1.94e-06	1.78e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—JUN—stomach cancer	1.93e-06	1.77e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCND1—stomach cancer	1.93e-06	1.77e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTP1—stomach cancer	1.93e-06	1.77e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—JUN—stomach cancer	1.93e-06	1.77e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	1.93e-06	1.77e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PPARG—stomach cancer	1.93e-06	1.77e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MMP9—stomach cancer	1.92e-06	1.76e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—HRAS—stomach cancer	1.92e-06	1.76e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—KRAS—stomach cancer	1.92e-06	1.76e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CDKN1A—stomach cancer	1.91e-06	1.76e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCND1—stomach cancer	1.91e-06	1.76e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—JUN—stomach cancer	1.91e-06	1.75e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCND1—stomach cancer	1.91e-06	1.75e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—JUN—stomach cancer	1.9e-06	1.75e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—HMOX1—stomach cancer	1.9e-06	1.75e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	1.9e-06	1.75e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	1.9e-06	1.75e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ALB—stomach cancer	1.9e-06	1.74e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—PIK3CA—stomach cancer	1.89e-06	1.74e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TP53—stomach cancer	1.89e-06	1.74e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MMP9—stomach cancer	1.89e-06	1.74e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	1.89e-06	1.73e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MMP9—stomach cancer	1.89e-06	1.73e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	1.88e-06	1.73e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—STAT3—stomach cancer	1.88e-06	1.73e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MMP9—stomach cancer	1.88e-06	1.73e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CDKN1A—stomach cancer	1.88e-06	1.73e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MMP9—stomach cancer	1.87e-06	1.72e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	1.87e-06	1.72e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—PIK3CA—stomach cancer	1.87e-06	1.72e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MYC—stomach cancer	1.87e-06	1.72e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CAV1—stomach cancer	1.87e-06	1.72e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	1.87e-06	1.72e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MAPK8—stomach cancer	1.87e-06	1.72e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	1.87e-06	1.71e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOA1—stomach cancer	1.87e-06	1.71e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MAPK3—stomach cancer	1.86e-06	1.71e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	1.86e-06	1.7e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MMP9—stomach cancer	1.86e-06	1.7e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—ALB—stomach cancer	1.85e-06	1.7e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—STAT3—stomach cancer	1.85e-06	1.7e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MMP9—stomach cancer	1.85e-06	1.7e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	1.85e-06	1.7e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MAPK3—stomach cancer	1.85e-06	1.7e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	1.84e-06	1.69e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MAPK8—stomach cancer	1.84e-06	1.69e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL6—stomach cancer	1.84e-06	1.69e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MAPK8—stomach cancer	1.83e-06	1.68e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	1.83e-06	1.68e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EGFR—stomach cancer	1.83e-06	1.68e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—stomach cancer	1.83e-06	1.68e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MAPK8—stomach cancer	1.83e-06	1.68e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MAPK8—stomach cancer	1.82e-06	1.67e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—NOS3—stomach cancer	1.82e-06	1.67e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—stomach cancer	1.81e-06	1.66e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—HRAS—stomach cancer	1.81e-06	1.66e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL6—stomach cancer	1.81e-06	1.66e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MYC—stomach cancer	1.81e-06	1.66e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MAPK8—stomach cancer	1.8e-06	1.66e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	1.8e-06	1.65e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	1.8e-06	1.65e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MYC—stomach cancer	1.8e-06	1.65e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—TYMS—stomach cancer	1.79e-06	1.65e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.79e-06	1.64e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PIK3CA—stomach cancer	1.78e-06	1.63e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—NOS3—stomach cancer	1.77e-06	1.63e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTM1—stomach cancer	1.77e-06	1.63e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCND1—stomach cancer	1.77e-06	1.63e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	1.77e-06	1.63e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MAPK1—stomach cancer	1.77e-06	1.62e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EGFR—stomach cancer	1.77e-06	1.62e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—JUN—stomach cancer	1.77e-06	1.62e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—PIK3CA—stomach cancer	1.76e-06	1.62e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MAPK1—stomach cancer	1.76e-06	1.62e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EGFR—stomach cancer	1.76e-06	1.62e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—HRAS—stomach cancer	1.75e-06	1.61e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MYC—stomach cancer	1.75e-06	1.61e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ALB—stomach cancer	1.75e-06	1.6e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—HRAS—stomach cancer	1.73e-06	1.59e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6—stomach cancer	1.73e-06	1.59e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ALB—stomach cancer	1.73e-06	1.59e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—KRAS—stomach cancer	1.73e-06	1.59e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—stomach cancer	1.72e-06	1.58e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MYC—stomach cancer	1.72e-06	1.58e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MMP9—stomach cancer	1.72e-06	1.58e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	1.71e-06	1.57e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	1.71e-06	1.57e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EGFR—stomach cancer	1.71e-06	1.57e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—STAT3—stomach cancer	1.71e-06	1.57e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—stomach cancer	1.7e-06	1.56e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—stomach cancer	1.7e-06	1.56e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—stomach cancer	1.69e-06	1.56e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—stomach cancer	1.69e-06	1.55e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	1.68e-06	1.55e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EGFR—stomach cancer	1.68e-06	1.55e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—stomach cancer	1.68e-06	1.55e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—STAT3—stomach cancer	1.68e-06	1.54e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—STAT3—stomach cancer	1.68e-06	1.54e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6—stomach cancer	1.68e-06	1.54e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	1.67e-06	1.54e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—STAT3—stomach cancer	1.67e-06	1.53e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—NOS3—stomach cancer	1.67e-06	1.53e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—KRAS—stomach cancer	1.67e-06	1.53e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—stomach cancer	1.67e-06	1.53e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—STAT3—stomach cancer	1.67e-06	1.53e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ERCC2—stomach cancer	1.67e-06	1.53e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	1.66e-06	1.53e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—KRAS—stomach cancer	1.66e-06	1.53e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—stomach cancer	1.66e-06	1.53e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6—stomach cancer	1.66e-06	1.52e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—NOS3—stomach cancer	1.66e-06	1.52e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—STAT3—stomach cancer	1.65e-06	1.52e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—STAT3—stomach cancer	1.65e-06	1.51e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARG—stomach cancer	1.65e-06	1.51e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MAPK3—stomach cancer	1.63e-06	1.5e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—HRAS—stomach cancer	1.63e-06	1.5e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—stomach cancer	1.62e-06	1.49e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—KRAS—stomach cancer	1.62e-06	1.48e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MAPK3—stomach cancer	1.61e-06	1.47e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MAPK3—stomach cancer	1.6e-06	1.47e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MAPK3—stomach cancer	1.6e-06	1.47e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MAPK3—stomach cancer	1.59e-06	1.46e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—KRAS—stomach cancer	1.59e-06	1.46e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	1.59e-06	1.46e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MYC—stomach cancer	1.59e-06	1.46e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MAPK3—stomach cancer	1.58e-06	1.45e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	1.57e-06	1.44e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PIK3CA—stomach cancer	1.57e-06	1.44e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—MTHFR—stomach cancer	1.57e-06	1.44e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MYC—stomach cancer	1.56e-06	1.43e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6—stomach cancer	1.56e-06	1.43e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MYC—stomach cancer	1.56e-06	1.43e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MYC—stomach cancer	1.55e-06	1.43e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MAPK1—stomach cancer	1.55e-06	1.43e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EGFR—stomach cancer	1.55e-06	1.43e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MYC—stomach cancer	1.55e-06	1.42e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	1.54e-06	1.42e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—stomach cancer	1.54e-06	1.41e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	1.53e-06	1.41e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MYC—stomach cancer	1.53e-06	1.41e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MYC—stomach cancer	1.53e-06	1.4e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—STAT3—stomach cancer	1.53e-06	1.4e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MAPK1—stomach cancer	1.53e-06	1.4e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—stomach cancer	1.53e-06	1.4e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EGFR—stomach cancer	1.53e-06	1.4e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	1.53e-06	1.4e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MAPK1—stomach cancer	1.52e-06	1.4e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EGFR—stomach cancer	1.52e-06	1.4e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MAPK1—stomach cancer	1.52e-06	1.4e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EGFR—stomach cancer	1.52e-06	1.39e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MAPK1—stomach cancer	1.51e-06	1.39e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—stomach cancer	1.51e-06	1.39e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EGFR—stomach cancer	1.51e-06	1.39e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MAPK1—stomach cancer	1.5e-06	1.38e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EGFR—stomach cancer	1.5e-06	1.38e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	1.5e-06	1.37e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EGFR—stomach cancer	1.5e-06	1.37e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	1.48e-06	1.36e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—stomach cancer	1.48e-06	1.36e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ALB—stomach cancer	1.48e-06	1.36e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—stomach cancer	1.48e-06	1.36e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—HRAS—stomach cancer	1.47e-06	1.35e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—KRAS—stomach cancer	1.47e-06	1.35e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	1.46e-06	1.34e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	1.46e-06	1.34e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CAV1—stomach cancer	1.44e-06	1.33e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—KRAS—stomach cancer	1.44e-06	1.32e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PIK3CA—stomach cancer	1.44e-06	1.32e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOA1—stomach cancer	1.44e-06	1.32e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—KRAS—stomach cancer	1.44e-06	1.32e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—stomach cancer	1.44e-06	1.32e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—KRAS—stomach cancer	1.44e-06	1.32e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—KRAS—stomach cancer	1.43e-06	1.31e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MYC—stomach cancer	1.42e-06	1.3e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—HRAS—stomach cancer	1.42e-06	1.3e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—KRAS—stomach cancer	1.42e-06	1.3e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—NOS3—stomach cancer	1.41e-06	1.3e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—stomach cancer	1.41e-06	1.3e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—KRAS—stomach cancer	1.41e-06	1.3e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—HRAS—stomach cancer	1.41e-06	1.3e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6—stomach cancer	1.41e-06	1.29e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	1.39e-06	1.28e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EGFR—stomach cancer	1.39e-06	1.28e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—HRAS—stomach cancer	1.37e-06	1.26e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6—stomach cancer	1.36e-06	1.25e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—HRAS—stomach cancer	1.35e-06	1.24e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6—stomach cancer	1.35e-06	1.24e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PIK3CA—stomach cancer	1.35e-06	1.24e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	1.33e-06	1.22e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PIK3CA—stomach cancer	1.32e-06	1.21e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	1.32e-06	1.21e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6—stomach cancer	1.31e-06	1.21e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	1.31e-06	1.21e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—KRAS—stomach cancer	1.31e-06	1.21e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—stomach cancer	1.3e-06	1.2e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	1.3e-06	1.2e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	1.3e-06	1.19e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—stomach cancer	1.29e-06	1.19e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6—stomach cancer	1.29e-06	1.19e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—stomach cancer	1.28e-06	1.18e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—stomach cancer	1.28e-06	1.18e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—stomach cancer	1.28e-06	1.17e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—stomach cancer	1.27e-06	1.17e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARG—stomach cancer	1.27e-06	1.17e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—stomach cancer	1.26e-06	1.16e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—stomach cancer	1.26e-06	1.15e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—HRAS—stomach cancer	1.25e-06	1.14e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—HRAS—stomach cancer	1.23e-06	1.13e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—HRAS—stomach cancer	1.22e-06	1.12e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—HRAS—stomach cancer	1.22e-06	1.12e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—HRAS—stomach cancer	1.22e-06	1.12e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	1.21e-06	1.11e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—HRAS—stomach cancer	1.2e-06	1.11e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—HRAS—stomach cancer	1.2e-06	1.1e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6—stomach cancer	1.19e-06	1.1e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6—stomach cancer	1.17e-06	1.08e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6—stomach cancer	1.17e-06	1.08e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6—stomach cancer	1.17e-06	1.07e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—stomach cancer	1.17e-06	1.07e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6—stomach cancer	1.16e-06	1.07e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6—stomach cancer	1.15e-06	1.06e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6—stomach cancer	1.15e-06	1.06e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ALB—stomach cancer	1.14e-06	1.05e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—HRAS—stomach cancer	1.12e-06	1.02e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NOS3—stomach cancer	1.09e-06	1e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6—stomach cancer	1.07e-06	9.81e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.02e-06	9.38e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—stomach cancer	9.99e-07	9.17e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CA—stomach cancer	9.97e-07	9.16e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CA—stomach cancer	9.4e-07	8.63e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CA—stomach cancer	9.32e-07	8.56e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CA—stomach cancer	7.96e-07	7.31e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CA—stomach cancer	6.14e-07	5.64e-06	CbGpPWpGaD
